A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
American Regent launches FDA-approved injectable Atropine Sulfate; drug serves as temporary blockade of severe, life-threatening muscarinic effects, as an organophosphorus, muscarinic mushroom poisoning antidote, and to treat bradyasystolic cardiac arrest
Published:
August 10, 2022
by PR Newswire
|
Assure Infusions building 60,000 square-foot, fully automated IV fluid manufacturing plant in Bartow, Florida, to open in 2023; Assure launched in 2022 to make sterile IV fluids such as dextrose, Ringer’s lactate, normal saline, sterile water
Published:
August 10, 2022
by Business Wire
|
FDA to conduct clinical trial of Siga Technologies’ Tpoxx tecovirimat oral and injectable antiviral as a treatment for monkeypox; CDC reports 7,510 monkeypox cases in US
Published:
August 09, 2022
by SeeNews Pharmaceuticals
|
FDA starts priority review of Eli Lilly’s donanemab injectable Alzheimer drug designed to clear amyloid plaque from brain; late-stage study results expected by middle of 2023
Published:
August 08, 2022
by SeeNews Pharmaceuticals
|
Regeneron ends four early-to-late stage clinical trials of injectable REGEN-COV because emerging SARS-CoV-2 variants are impacting studies; studies involved drug as treatment for hospitalized children, non-hospitalized patients
Published:
August 04, 2022
by FiercePharma
|
Ask us about our Tissue & Hygiene market view
Trending Chart
Interactive chart with headline count